Advertisement
Screener

Edwards Lifesciences Corporation (EW) Deferred Income Tax Liabilities, Net

2.8 / 5 stars · 68/120 Roast Me

Edwards Lifesciences Corporation Deferred Income Tax Liabilities, Net

Edwards Lifesciences Corporation (EW) had Deferred Income Tax Liabilities, Net of $36.60 million as of 2020-09-30, per its 10-Q filed 2020-10-26.

Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent

us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2020-10-26

  • 2020-09-30: Deferred Income Tax Liabilities, Net $36.60M.
  • 2020-06-30: Deferred Income Tax Liabilities, Net $36.80M.
  • 2019-12-31: Deferred Income Tax Liabilities, Net $36.90M.
Period endDeferred Income Tax Liabilities, Net
2020-09-30$36.60M
10-Q · filed 2020-10-26
2020-06-30$36.80M
10-Q · filed 2020-07-27
2019-12-31$36.90M
10-Q · filed 2020-10-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00